National Wilm's Tumor Study Late Effects
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00228696 |
Recruitment Status :
Withdrawn
(national study, local site not responsible for results/analysis)
First Posted : September 29, 2005
Last Update Posted : November 26, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Wilm's Tumor | Other: none, screening only | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 0 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | National Wilm's Tumor Study Late Effects |
Study Start Date : | September 2005 |
Estimated Primary Completion Date : | December 2010 |
Estimated Study Completion Date : | December 2011 |

Arm | Intervention/treatment |
---|---|
No Intervention: screening
this is a screening study and no intervention.
|
Other: none, screening only
Screening protocol with no intervention |
- To determine if survivors from Wilms tumors or their offspring are at risk for adverse medical conditions. [ Time Frame: 1 year after closure of study ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Previously enrolled in NWTS 5.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00228696
United States, Georgia | |
Children's Healthcare of Atlanta | |
Atlanta, Georgia, United States, 30322 |
Principal Investigator: | Howard Katzenstein, MD | Children's Healthcare of Atlanta |
Responsible Party: | Howard Katzenstein, Associate Professor, Emory University |
ClinicalTrials.gov Identifier: | NCT00228696 History of Changes |
Other Study ID Numbers: |
IRB00024842 |
First Posted: | September 29, 2005 Key Record Dates |
Last Update Posted: | November 26, 2013 |
Last Verified: | November 2013 |
late effects |
Wilms Tumor Neoplasms, Complex and Mixed Neoplasms by Histologic Type Neoplasms Kidney Neoplasms Urologic Neoplasms |
Urogenital Neoplasms Neoplasms by Site Neoplastic Syndromes, Hereditary Kidney Diseases Urologic Diseases Genetic Diseases, Inborn |